We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-7.92%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$670M
AUM Growth
-$18.2M
Cap. Flow
-$335M
Cap. Flow %
-50.06%
Top 10 Hldgs %
86.43%
Holding
215
New
27
Increased
46
Reduced
57
Closed
68

Top Buys

Rank Stock Value
1
NRXP icon
NRX Pharmaceuticals
NRXP
+$2.55M
2
TANH icon
Tantech Holdings
TANH
+$2.26M
3
AGTC
Applied Genetic Technologies Corporation
AGTC
+$1.76M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$1.52M
5
NBEV
NewAge, Inc. Common Stock (Delaware)
NBEV
+$1.12M

Top Sells

Rank Stock Value
1
BTBT icon
Bit Digital
BTBT
+$17.7M
2
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$10.2M
3
ROI
RiskOn International, Inc. Common Stock
ROI
+$7.16M
4
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$5.75M
5
SLAI
SOLAI Ltd ADS
SLAI
+$5.55M

Sector Composition

Rank Sector Weight
1 Healthcare 7.59%
2 Technology 1.45%
3 Financials 0.54%
4 Consumer Discretionary 0.53%
5 Consumer Staples 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCDA
126
PUT
DELISTED
Tricida, Inc. Common Stock
TCDA
$59K 0.01%
1,229
+113
+10% +$1.02K
NMTR
127
PUT
DELISTED
9 Meters Biopharma
NMTR
$50K 0.01%
6
-154
-96% -$2.1K
ESPR
128
CALL
DELISTED
Esperion Therapeutics
ESPR
$46K 0.01%
+100
New +$429
IMG
129
PUT
DELISTED
CIMG Inc
IMG
– –
0
– –
XELA
130
PUT
DELISTED
Exela Technologies, Inc. Common Stock
XELA
– –
-1
Closed -$2.51K
ANY icon
131
CALL
Sphere 3D
ANY
$15.7M
$37K 0.01%
3
– –
BBLGW
132
Bone Biologics Corp Warrants
BBLGW
$32.7M
$37K 0.01%
3,616
-1,900
-34% -$25.3K
BXRX
133
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$33K ﹤0.01%
+473
New +$87.3K
XELA
134
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$29K ﹤0.01%
18
-34
-65% -$85.4K
EQOS
135
PUT
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$28K ﹤0.01%
+125
New +$237
STAB
136
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$22K ﹤0.01%
69,103
-315,494
-82% -$337K
EVFM
137
PUT
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$16K ﹤0.01%
32
-60
-65% -$377
AGTC
138
CALL
DELISTED
Applied Genetic Technologies Corporation
AGTC
$15K ﹤0.01%
+140
New +$254
CHAI
139
Core AI Holdings Inc
CHAI
$9.78M
– –
0
– –
FEED
140
ENvue Medical Inc
FEED
$2.01M
$12K ﹤0.01%
5
– –
GMBLW
141
PUT
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLW
$7K ﹤0.01%
+100
New +$115
HCDIP
142
DELISTED
Harbor Custom Development, Inc. 8.0% Series A Cumulative Convertible Preferred Stock, no par value
HCDIP
– –
0
– –
SRGA
143
PUT
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$4K ﹤0.01%
4
-55
-93% -$836
GROMW
144
DELISTED
Grom Social Enterprises Inc. Warrants
GROMW
$3K ﹤0.01%
425
– –
AEI icon
145
Alset
AEI
$40.8M
– –
-164,516
Closed -$1.84M
AMRN
146
CALL
Amarin Corp
AMRN
$297M
– –
-442
Closed -$2.98M
AMRN
147
Amarin Corp
AMRN
$297M
– –
-17,403
Closed -$1.17M
AMRN
148
PUT
Amarin Corp
AMRN
$297M
– –
-228
Closed -$1.54M
ATNM icon
149
Actinium Pharmaceuticals
ATNM
$26.3M
– –
-73,366
Closed -$386K
AUPH icon
150
CALL
Aurinia Pharmaceuticals
AUPH
$1.95B
– –
-469
Closed -$1.07M
4 5
6
7 8

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AB
Aozora Bank Tokyo, Japan $43.6M AUM 1.15% 1-Year Est. Return

Sabby Management's Q1 2022 Portfolio in Review

As of Q1 2022, Sabby Management held 215 positions worth $670M, down 2.6% from $688M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Sabby Management withdrew a net $335M in Q1 2022, closing 68 positions and reducing 57 holdings. Its most notable exit was Bit Digital, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 7.4% a quarter earlier, followed by Technology and Financials.

Against the trend, Sabby Management opened a new position in NRX Pharmaceuticals worth $1.92M.

  • Sabby Management's largest Q1 2022 buy was NRX Pharmaceuticals: 78,247 shares worth $1.92M.
  • Sabby Management added most to Tantech Holdings in Q1 2022, an estimated $2.26M increase.
  • Sabby Management's biggest Q1 2022 reduction was SOLAI Ltd ADS, cutting an estimated $5.55M.
  • Sabby Management fully exited Bit Digital in Q1 2022, selling an estimated $17.7M.
  • Sabby Management's ten largest holdings make up 86% of its $670M portfolio in Q1 2022.
  • Sabby Management opened 27 new positions and closed 68 in Q1 2022.
  • Sabby Management's portfolio value fell 2.6% quarter-over-quarter to $670M.

Based on Sabby Management's 13F filing for Q1 2022, filed 16 May 2022.